1Senior Consultant, Department of Radiotherapy, Labaid Cancer Hospital & Amp, Super Specialty Center, Dhaka, Bangladesh
2Manager, Oncology, Beacon Pharmaceuticals Limited, Dhaka, Bangladesh
American Journal of Cancer Prevention.
2023,
Vol. 10 No. 1, 12-13
DOI: 10.12691/ajcp-10-1-3
Copyright © 2023 Science and Education PublishingCite this paper: Ehteshamul Hoque, Safayet Hossain. Metastatic or Recurrent Head & Neck Cancer: New Hope with Immunotherapy.
American Journal of Cancer Prevention. 2023; 10(1):12-13. doi: 10.12691/ajcp-10-1-3.
Correspondence to: Ehteshamul Hoque, Senior Consultant, Department of Radiotherapy, Labaid Cancer Hospital & Amp, Super Specialty Center, Dhaka, Bangladesh. Email:
ehtesham@dhaka.netAbstract
Introduction: The recurrence of any type of cancer can be a great physical, mental and financial burden for the patients, and can also negatively impact the overall health status of a country. Despite the availability of multiple treatment methods, patients with recurrence of cancer still show up. Which is why, the present study of 2 recurrent carcinoma patients, who after being treated with immunotherapy, did no see any recurrence and observed significant clinical and radiological improvement, is of great importance. Case Presentation: This study was conducted with 2 cases of recurrent head and neck cancer, both of whom were Bangladeshi female. The first patient was 70-year-old, while the second patient was 59 years old. Both had received multiple previous treatment, including surgical treatment and chemotherapy, but still had recurrence of cancer. Conclusion: The use of immunotherapy in recurring Head & Neck Cancer shows promising Clinical and Radiological response, with much fewer observable side-effects compared to previous treatment methods.
Keywords